Stories
Karnataka Fake Drug Racket: FDA Tracks Patients, Uncovers Supply Chain of Spurious Medicines
N
News18•21-09-2026, 13:11
Karnataka Fake Drug Racket: FDA Tracks Patients, Uncovers Supply Chain of Spurious Medicines
- •The Karnataka Food and Drug Administration (FDA) has initiated tracking patients who received suspected spurious medicines as part of the ongoing fake drug racket investigation.
- •Officials are meticulously tracing the supply chain to identify hospitals, pharmacies, and medical stores that received the counterfeit drugs.
- •Karnataka Assembly Speaker U.T. Khader confirmed that the FDA is collecting patient details to ascertain if they experienced health issues after consuming the fake medicines.
- •The FDA is gathering purchase and distribution records, including batch details and usage dates, from medical stores and hospital pharmacies.
- •The patient-tracking exercise aims to assess the impact of the fake drugs on health and guide future actions against the racket.
Key Questions Answered
FDA officials are collecting purchase and distribution records from medical stores and hospital pharmacies, including batch details and supply dates, to identify patients who received the spurious medicines and contact them regarding any potential health problems.
The Karnataka Food Safety and Drugs Administration has cancelled 16 pharmacy licences and suspended eight others following the investigation into the counterfeit medicine network.
Investigators found that low-cost medicines were repackaged and relabelled to mimic expensive life-saving drugs, multinational brands, ICU injections, and cancer medications.
